Potential of Small Molecule Protein Tyrosine Kinase Inhibitors as Immunomodulators and Inhibitors of the Development of Diabetes

被引：17
|
作者：
Little, Peter J. [1 ,2 ,3 ]
Cohen, Neale [4 ]
Morahan, Grant [5 ]
机构：
[1] BakerIDI Heart & Diabet Inst, Diabet & Cell Biol Lab, Melbourne, Vic 3004, Australia
[2] Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Dept Med, Melbourne, Vic 3004, Australia
[3] Monash Univ, Alfred Hosp, Cent & Eastern Clin Sch, Dept Immunol, Melbourne, Vic 3004, Australia
[4] BakerIDI Heart & Diabet Inst, Clin Serv Div, Melbourne, Vic 3004, Australia
[5] Western Australian Inst Med Res, Ctr Diabet Res, Perth, WA 6000, Australia
来源：
THESCIENTIFICWORLDJOURNAL | 2009年 / 9卷
基金：
英国医学研究理事会;
关键词：
Type; 1; diabetes; 2; imatinib; autoimmunity; NOD mouse; ENDOPLASMIC-RETICULUM STRESS; IMATINIB-MESYLATE; INSULIN SENSITIVITY; BLOOD-GLUCOSE; RISK; CHILDREN; MICE; LIFE;
D O I：
10.1100/tsw.2009.28
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
[No abstract available]
引用
收藏
页码：224 / 228
页数：5
相关论文
共 50 条
  • [1] Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes
    Mokhtari, Dariush
    Welsh, Nils
    CLINICAL SCIENCE, 2010, 118 (3-4) : 241 - 247
  • [2] Small molecule tyrosine kinase inhibitors in glioblastoma
    Gayoung Kim
    Young Tag Ko
    Archives of Pharmacal Research, 2020, 43 : 385 - 394
  • [3] Small molecule tyrosine kinase inhibitors in glioblastoma
    Kim, Gayoung
    Ko, Young Tag
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (04) : 385 - 394
  • [4] Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors
    Hamby, JM
    Showalter, HDH
    PHARMACOLOGY & THERAPEUTICS, 1999, 82 (2-3) : 169 - 193
  • [5] Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents
    Laird, AD
    Cherrington, JM
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (01) : 51 - 64
  • [6] Hematologic toxicities of small molecule tyrosine kinase inhibitors
    Nicholas A. Barber
    Wais Afzal
    Mojtaba Akhtari
    Targeted Oncology, 2011, 6 : 203 - 215
  • [7] Hematologic toxicities of small molecule tyrosine kinase inhibitors
    Barber, Nicholas A.
    Afzal, Wais
    Akhtari, Mojtaba
    TARGETED ONCOLOGY, 2011, 6 (04) : 203 - 215
  • [8] Small-molecule tyrosine kinase inhibitors as radiosensitizers
    Lawrence, TS
    Nyati, MK
    SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (03) : 33 - 36
  • [9] Small molecule tyrosine kinase inhibitors in pancreatic cancer
    Gupta, Sachin
    El-Rayes, Bassel F.
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 707 - 715
  • [10] Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
    Roskoski, Robert, Jr.
    PHARMACOLOGICAL RESEARCH, 2015, 94 : 9 - 25
12345